Analysis of transcription factor interactions in osteoblasts using competitive chromatin immunoprecipitation by Roca, Hernan & Franceschi, Renny T.
Published online 7 February 2008 Nucleic Acids Research, 2008, Vol. 36, No. 5 1723–1730
doi:10.1093/nar/gkn022
Analysis of transcription factor interactions
in osteoblasts using competitive chromatin
immunoprecipitation
Hernan Roca
1 and Renny T. Franceschi
1,2,*
1Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry and
2Department of
Biological Chemistry, University of Michigan School of Medicine, Ann Arbor, MI, USA
Received November 11, 2007; Revised January 13, 2008; Accepted January 14, 2008
ABSTRACT
Chromatin immunoprecipitation (ChIP) is a widely
used technique for quantifying protein–DNA interac-
tions in living cells. This method commonly uses
fixed (crosslinked) chromatin that is fragmented by
sonication (X-ChIP). We developed a simple new
ChIP procedure for the immunoprecipitation of son-
icated chromatin isolated from osteoblasts in the
absence of crosslinking (N-ChIP). The use of non-
crosslinked chromatin allowed development of a
new modification of the ChIP assay: the combination
of N-ChIP and competition with double-stranded
oligonucleotides containing specific binding sites
for individual transcription factors (Competitive
N-ChIP). Using this approach, we were able to dis-
criminate between individual binding sites for the
Runx2 transcription factor in the osteocalcin and
bone sialoprotein genes that cannot be resolved by
traditional X-ChIP. N-ChIP assays were also able to
detect several other types of chromatin interactions
including those with Dlx homeodomain factors and
nuclear proteins such as Sin3a that lack an intrinsic
DNA-binding motif and, therefore, bind to chromatin
via interactions with other proteins.
INTRODUCTION
Transcriptional control of gene expression is a major
mechanism for regulating cellular activity and diﬀerentia-
tion. Dysregulation of certain transcription factors plays a
signiﬁcant role in the etiology of many diseases including
disorders of skeletal development and cancer. In bone,
mutations in the Runx2 transcription factor cause
cleidocranial dysplasia, a human disorder characterized
by hypoplastic clavicles, patent fontanelles, supernumer-
ary teeth and short stature (1) while translocations of
Runx3 (AML-1) are associated with acute myelogenous
leukemias (2). Therefore, an understanding of transcrip-
tion factors and their targets is of central interest to bone
biology and medicine.
A considerable eﬀort has been devoted toward the
development of methods for identifying in vivo chromatin-
binding sites for transcription factors. Using a bioinfor-
matics approach, sequence-based methods for deﬁning
putative transcription factor-binding sites have been
developed and hundreds of consensus binding sequences
deﬁned (3). However, the predictive ability of this
approach is limited by a number of factors including
DNA methylation, nucleosomal positioning and adjacent
DNA sequences that aﬀect binding speciﬁcity (4,5). For
example, based on sequence information, we identiﬁed a
putative Runx2 binding site in the bone sialoprotein
promoter that contains a perfect consensus Runx2-
binding region. Furthermore, this site binds Runx2 with
high aﬃnity and speciﬁcity in vitro. However, it is not
occupied by Runx2 in vivo as measured by chromatin
immunoprecipitation (ChIP) assays and is devoid of
enhancer activity (6). A second major concern with
computer-based approaches is that many true positives
may be overlooked if the transcription factor is recruited
to the DNA via a site that does not exactly match a
consensus site or by protein–protein interactions (7).
Thus, the lack of a strict consensus can make it diﬃcult
to identify true target promoters using only sequence
analysis software.
ChIP is a powerful and increasingly used technique for
determining the in vivo binding sites of transcription
factors as well as identifying epigenetic changes in
chromatin. There are two main types of ChIP assays
that diﬀer primarily in how the input chromatin is
prepared: X-ChIP and N-ChIP. The X-ChIP method, by
far the most commonly used approach, utilizes formalde-
hyde-ﬁxed chromatin that is fragmented by sonication or
enzymatically (8–11), while N-ChIP uses native, unﬁxed
chromatin solubilized by micrococcal nuclease digestion
(12,13). Both methods have advantages and disadvan-
tages (12). X-ChIP reduces the possibility of protein
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prevents chromatin from being fragmented to the desired
size and can disrupt epitopes necessary for antibody
recognition (10). On the other hand, the N-ChIP/nuclease
digestion approach provides a gentler means of shearing
chromatin, but is not generally useful for detecting
nonhistone proteins associated with internucleosomal
regions of DNA that are preferentially sensitive to
nuclease treatment.
Here we report a simple and eﬃcient ChIP procedure
that utilizes unﬁxed, native chromatin fragmented by
sonication and demonstrate that this method can be used
to detect chromatin binding by the bone-related Runx2
transcription factor and other osteoblast-associated
nuclear factors including those that do not bind directly
to DNA. In addition, we developed a modiﬁcation of the
N-ChIP approach involving oligonucleotide competition.
This approach allows discrimination between chromatin
sites that cannot be directly resolved by classical
ChIP assays. Using this approach, we were able to
resolve adjacent Runx2-binding sites in two osteoblast-
related genes encoding osteocalcin (Ocn) and bone
sialoprotein (Bsp).
MATERIALS AND METHODS
Cellculture
Subclone 4 MC3T3-E1 (MC-4) cells were maintained
in ascorbic acid-free alpha minimal essential medium
(a-MEM; Life Technologies, Inc., Grand Island, NY,
U.S.A.), 10% fetal bovine serum (FBS; Hyclone
Laboratories, Logan, UT, U.S.A.) and 1% penicillin/
streptomycin as previously described (14,15). Osteoblast
diﬀerentiation was induced by the addition of 50mg/ml
ascorbic acid (AA) to the medium for 5–6 days (16).
Antibodies
The anti-Runx2 (M-70; sc-10758), anti-Dlx6 (G20;
sc-18154) and the control preimmune goat and rabbit
IgGs were purchased from Santa Cruz Biotechnology.
The anti-Sin3A (cat# 06-913) and anti-acetyl Histone 3
(cat# 06-599) were obtained from Millipore Upstate (Lake
Placid, NY).
Native ChIP assays
N-ChIP assays were performed using diﬀerentiated MC-4
cells. Cells were washed twice with cold PBS and harvested
by gentle scraping in PBS containing protease inhibitors
[1mM phenylmethylsulfonyl ﬂuoride (PMSF) and 1% v/v
Protease Inhibitor Cocktail (PIC) (Sigma)]. Cell pellets
were resuspended in Lysis Buﬀer [0.25% Triton X-100,
10mM Tris pH 8, 10mM EDTA (pH 8), 0.5mM EGTA
(pH8), 200mM NaCl and protease inhibitors (PMSF and
PIC)] and homogenized with three to ﬁve strokes of a
Teﬂon pestle homogenizer. After centrifugation at 200g
for 5min, crude nuclei were resuspended in sonication
buﬀer [10mM Tris–HCl (pH 8), 1mM EDTA, 0.1% SDS
and PIC (Sigma)] and sonicated for 10s. 5–10 times at 48C
to reduce the average DNA length to 0.4–0.5kb. Cellular
debris were removed by high-speed centrifugation
(>13000r.p.m. in a microcentrifuge) for 30min at 48C.
The amount of soluble chromatin was quantiﬁed using the
PicoGreen ds DNA Quantitation Assay and a phage
lambda DNA standard (Molecular Probes, Invitrogen)
according to manufacture’s instructions. Chromatin con-
taining 10mg DNA (input) was used as starting material in
each ChIP reaction. Samples were diluted to 1ml with IP
buﬀer (10mM Tris–HCl, pH 8, 150mM NaCl, 1% Triton
X-100, 0.1% w/v sodium deoxycolate, 100mg/ml BSA,
10mg/ml yeast tRNA, and protease inhibitors, PMSF and
PIC). Prior to immunoprecipitation, input chromatin was
pre-cleared by adding 50ml of protein A/G-agarose (Santa
Cruz Biotechnology) and rotating the tubes for 1h at 48C.
The supernatant was recovered by 1min centrifugation at
5000r.p.m. in a microcentrifuge. ChIP reactions were
initiated by the addition of 2mg of speciﬁc antibody
(Runx2, Dlx6, Sin3A or Ac-H3) or control antibody
(rabbit or goat IgG) and samples were incubated over-
night at 48C. Immune complexes were isolated by adding
50ml of protein A/G-agarose, rotating for 1h at 48C and
collecting beads by centrifugation for 1min at 5000r.p.m..
Beads were washed three times with 1ml of IP buﬀer,
twice with TE buﬀer (10mM Tris–HCl, 1mM EDTA, pH
8 and PMSF) and the immunocomplexes were eluted by
resuspending the beads in 150ml of elution buﬀer [10mM
Tris–HCl, 10mM EDTA (pH 8), 1% SDS] and heating at
658C for 15min The supernatant was recovered by
centrifugation at 5000r.p.m. for 1min and the samples
were digested with 0.2mg/ml Proteinase K for 2h at 458C.
ChIP-DNA was puriﬁed using the QIAquick Nucleotide
Removal Kit (Qiagen) according to manufacture’s
instructions. Fractions of the puriﬁed ChIP DNA (5%)
or Inputs (0.02–0.05%) were used for PCR analysis.
The PCR reaction was performed with AmpliTaq Gold
DNA Polymerase (Applied Biosystems) for 30 cycles
of 30s at 958C, 30s at 608C and 15s at 728Ci na
thermocycler (PTC 200, MJ Research, U.S.A). Primers
used (P1-8) are listed in Table 1. PCR products were
separated on 3% agarose gels containing 0.5mg/ml of
ethidium bromide and the DNA bands visualized with
ultraviolet light. For the N-ChIP competition assays,
the ds-oligonucleotides shown in Table 1 were added to
the immunoprecipitation reactions just before incubation
with the antibody. All ChIP assays were repeated at least
three times.
X-ChIP assays used the same protocol described
above except that before scraping in PBS, cells were
ﬁrst cross-linked with 1.1% formaldehyde for 10min
followed by neutralization with 2.5M glycine (5% v/v).
Electrophoresis mobility shift assays (EMSA) were carried
out as previously described(6).
Real-time PCR
The quantiﬁcation of ChIP-DNA by Real-time PCR
was performed using the TaqMan Universal PCR master
mix (Applied Biosystems, Foster City, CA) as well as
the combination of primers P1-P2 or P3-P4 described
in Table 1 and one of the following TaqMan probes
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respectively:
(i) OSE2a-(FAM/TAMRA probe)- CAGCTGCAAT
CACCAACCACAGCA and (ii) OSE2b-(FAM/TAMRA
probe)- TCCCCACCAACCACAAGAAATGCC.
RESULTS
Development of an N-ChiP method using mechanically
sheared chromatin
The idea of conducting ChIP assays with noncrosslinked
chromatin originated in the course of studies to analyze
interactions between the Runx2 transcription factor and
its cognate sequences in the promoters of genes expressed
during osteoblast diﬀerentiation. Our initial hypothesis
was that, if interactions of Runx2 with chromatin were
strong enough, they should survive the sonication
procedure used to shear chromatin and be detectable by
ChIP in the absence of crosslinking. Under these
conditions, chromatin proteins would remain in the
native state, which would facilitate subsequent analysis
or puriﬁcation. In addition, noncrosslinked chromatin
could be used to study protein–DNA interactions in native
chromatin using oligonucleotide competition.
We ﬁrst tested this hypothesis using the osteocalcin
(Ocn) promoter. Runx2 is a key regulator of osteoblast-
speciﬁc gene expression via its binding to consensus Runt
domain protein-binding elements present in Ocn and other
osteoblast-associated genes (17,18). Mouse Ocn contains
two such sites designated OSE2a and OSE2b located at
 130 and  605bp, respectively, relative to the transcrip-
tion start site (Figure 1A). Previous work showed
diﬀerences in the in vitro aﬃnity of these sites for Runx2
and in their relative ability to contribute to Ocn promoter
activity (19). Therefore, Ocn is a good model system to
test the speciﬁcity of the N-ChIP approach as well as to
compare interactions between a transcription factor and
two very similar, but functionally distinct regulatory
elements.
Before commencing N-ChIP analysis of Ocn, we ﬁrst
conducted a control study to evaluate whether ChIP
assays are capable of resolving binding of Runx2 to
OSE2a versus OSE2b sites. Because the average size of
chromatin used in ChIP is 400–500bp and OSE2a and
OSE2b are only 500bp apart, it is possible that both sites
might be precipitated on the same chromatin fragment,
thereby precluding their separate analysis. To address this
issue, sheared, formaldehyde cross-linked chromatin was
prepared and X-ChIP assays were carried out using a
speciﬁc anti-Runx2 antibody and the primer pairs shown
in Figure 1A and Table 1. Primer pairs were selected to
amplify OSE2a (P1, P2), an OSE2b-containing fragment
503-bp upstream from OSE2a (P3, P4) as well as a third
region located a similar distance (441bp) downstream
from OSE2a in the Ocn transcribed region that does not
contain any Runx2-binding sites (P5, P6). We reasoned
that if chromatin fragments large enough to contain both
OSE2a and OSE2b were present in ChIP reactions,
similarly sized fragments containing OSE2a and the
region ampliﬁed by P5/P6 should also be present. If so,
all three primer pairs would give a positive PCR signal
after ChIP with the Runx2 antibody. As shown in
Figure 1B, this was not seen. Instead, positive ChIP
signals were obtained for P1/P2 and P3/P4 primer pairs,
but not for P5/P6. Based on this result, we conclude that
Runx2 is separately bound to both OSE2a and OSE2b
and that occupancy of these sites can be individually
analyzed on ChIP using P1/P2 and P3/P4 primers.
To conduct N-ChIP assays, chromatin isolation and
shearing was conducted as for X-ChIP except that
the formaldehyde cross-linking step was omitted (see
Materials and Methods section). Results of a representa-
tive N-ChIP assay for the Ocn promoter using P1, P2 and
P3, P4 PCR primers is shown in Figure 1C. Interactions of
Runx2 with both OSE2 sites are easily detected (lanes 1, 2
and 9). PCR band intensities were comparable to those
obtained with X-ChIP (Figure 1B), indicating that Runx2
forms a stable complex with chromatin that is able to
survive isolation and shearing procedures.
Competitive ChIP assay ofRunx2 binding to chromatin
using OSE2-containing oligonucleotides
Because Runx2 is not crosslinked to chromatin in
N-ChIP, it exists in an equilibrium between chromatin
bound and free states. Therefore, it should be possible to
preferentially dissociate Runx2 from chromatin with an
excess of speciﬁc competitor double-stranded oligonucleo-
tide containing an intact OSE2a site. Competitor oligo
(C-OSE2a) was added to immunoprecipitation reactions
just before incubation with antibodies. As shown
in Figure 1C lanes 3–5, increasing concentrations of
C-OSE2a we were able to gradually dissociate Runx2
from both OSE2a and OSE2b chromatin sites. In contrast,
the same concentrations of mutant oligo, M-OSE2a
[contains a 2-bp mutation in the OSE2 site that abolishes
Runx2 binding in vitro (15)], was not able to displace
Table 1. Oligonucleotides used in this study
Oligo name Sequence
C-OSE2 CAGCTGCAATCACCAACCACAGCATC
M-OSE2 CAGCTGCAATCACCAAgaACAGCATC
C-R1 GATTCTCTGGTGAGAACCCACAGCCTG
M-R1a GATTCTCTGGTGAGAACgaACAGCCTG
M-R1b GATTCTCTtcTGAGAACCCACAGCCTG
C-R2 CACCCTTCAATTAAATCCCACAATGCA
M-R2 CACCCTTCAATTAAATCgaACAATGCA
C-R3 TCTTTTGTGGTTCTCTATTTTATTTTT
M-R3 TCTTTTGTtcTTCTCTATTTTATTTTT
P1 CTCAGTGGGTCAAACCCAAAG
P2 CGTCCACTCCCAGAGCCTT
P3 TGCCTCCATAAGATCCGGTT
P4 CCCACAATGGGCTAGGCTC
P5 CTGCCAGGCTTCCTGCTAGT
P6 TACAGATGCCAAGCCCAGC
P7 GCCTCAGTTGAATAAACATGAAA
P8 TCCTCACCCTTCAATTAAATCCCACAA
OP1 AGTGATGTGTCATGAGGTTTTTGC
OP2 TAACCACAAAACCAGAGGAGGAA
Note that for double stranded (ds) oligos used in N-ChIP competition
assays, only one strand is shown. Mutated bases in the oligos are
designated using bold lowercase letters.
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competition experiments, we analyzed ChIP results using
Real-time PCR. Figure1D summarizes these results
expressed as ChIP DNA ratio relative to zero competing
oligo from triplicate independent experiments, using both
primer pairs (P1, P2) or (P3, P4). The real-time results
conﬁrmed that only the speciﬁc oligo (C-OSEa) was able
to compete Runx2 away from OSE2a and OSE2b
chromatin sites. Of further interest, diﬀerences were also
noted when oligo competition was compared between
OSE2a and b sites. Speciﬁcally, a 75nM concentration of
C-OSE2a more eﬀectively competed Runx2 from the
OSE2b chromatin site (ampliﬁed by P3, P4 primers) than
from the OSE2a site (primers P1, P2). This is consistent
with previously reported EMSA results showing that even
though the core runt-binding site sequences of OSE2a and
b are identical, Runx2 binds to OSE2b with lower aﬃnity
than OSE2a (19).
To further validate the N-ChIP competition assay, we
examined a second osteoblast-related gene, osteopontin
(Opn). Like Ocn, Opn is transcriptionally regulated by
Runx2 via binding to a site located in the proximal
promoter at  136bp (20). This site has the same core
sequence (AACCACA) as OSE2a and b (see Figure 1E,
lower panel). PCR primers (OP1, OP2) were designed to
speciﬁcally amplify DNA from this promoter region. As
shown in Figure 1E (upper panel), N-ChIP was able to
detect in vivo association of Runx2 with this site and,
furthermore, binding was speciﬁcally competed with the
C-OSE2a (but not M-OSE2a) oligo.
Figure 1. Analysis of RUNX2 binding to the Ocn and Opn promoters in diﬀerentiated MC-4 cells using competitive N-ChIP. (A) Schematic
representation of Runx2-binding sites in the proximal murine Ocn promoter. The positions of the RUNX2-binding sites, OSE2a and OSE2b, relative
to the transcription start site are shown. P1, P2, P3, P4, P5 and P6 represent the diﬀerent PCR primers used for the analysis of ChIP DNA (see
Table 1). P1-P2 and P3-P4 were used to analyze the Runx2 binding to OSE2a and OSE2b, respectively. The sizes of the fragments they amplify are
indicated at the bottom of the ﬁgure. (B) Primers pairs (P1, P2) and (P3, P4) speciﬁcally detect Runx2 interactions with OSE2a and OSE2b,
respectively. Shown is the analysis of PCR products obtained with two independent X-ChIP-DNA samples obtained using Runx2 antibody and
diﬀerent primer pairs: P1-P2, P3-P4 and P5-P6 (see panel A). Control PCRs were done with duplicate samples of Input-DNAs and without DNA for
each primer combination. Note that the P5-P6 primer pair ampliﬁes a DNA fragment 441-bp away from OSE2a and that these primers do not
produce a PCR product with ChIP-DNA (lanes 12 and 13). In contrast, the fragment ampliﬁed by the P3-P4 primer pair is a similar distance (503bp)
from OSE2a and, in this case the PCR is clearly positive (lanes 7 and 8). (C) N-ChIP competition assay for the Ocn promoter. The C-OSE2a double-
stranded oligonucleotide or the mutant M-OSE2a was added at increasing concentrations (75, 375 and 750nM) to immunoprecipitation reactions.
A control reaction was also performed with normal rabbit IgG. The gels are ethidium bromide-stained agarose gels of the PCR products obtained
with ChIP DNAs using the Ocn promoter-primers P1-P2 (top) and P3-P4 (bottom). (D) Real-time PCR analysis of the N-ChIP-competition assay.
ChIP-DNAs were quantiﬁed by real-time PCR using two primer-pairs, P1-P2 and P3-P4, and their respective TaqMan probes. Results are expressed
as ChIP-DNA ratio relative to zero competing-oligo from two independent experiments. The legend indicates the primer pair used in the PCR and,
in parenthesis, the competing-oligo used for each ChIP-DNA set of samples. (E) N-ChIP competition assay for the Opn promoter. ChIP-DNAs were
analyzed by PCR using the Opn promoter primers OP1 and OP2. These primers correspond to the region near the Runx2-binding site in the Opn
promoter ( 130 to  136) having the same sequence as the OSE2 site (AACCACA, lower panel).
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To assess the degree to which N-ChIP can be used to
detect the association of other transcriptional regulators
with osteoblast chromatin, we carried out the experiment
depicted in Figure 2. Native sheared chromatin was
immunoprecipitated using antibodies speciﬁc to Runx2,
Dlx6, mSin3A or acetylated-histone 3 and proximal Ocn
promoter sequences were ampliﬁed using P1 and P2
primers (see Figure 1A). As negative controls, we used
preimmune IgG (from rabbit and goat). Speciﬁc associa-
tion with a chromatin fragment in the Ocn promoter was
revealed not only for Runx2 and the acetylated histone
H3, but also for two other transcriptional regulators, Dlx6
and Sin3A (Figure 2, lanes 2 and 3). The speciﬁc
interactions of Dlx6 and Sin3A with the Ocn promoter
were also detected by X-ChIP (data not shown). Dlx6 and
the related Dlx5 and Dlx3 belong to a subfamily of
homeodomain-containing transcription factors that play
important roles in osteoblast-speciﬁc gene expression and
skeletal development (21,22). In fact, speciﬁc siRNA for
Dlx6 that substantially reduced its mRNA levels, also
dramatically inhibited the expression of the Ocn gene
(Roca and Franceschi, unpublished data). Dlx proteins
are known to speciﬁcally bind a homeodomain protein-
binding element in the proximal Ocn promoter(23,24). Of
particular interest, Sin3A was also found to associate with
chromatin using the N-ChIP method. Sin3A is a global
transcriptional regulator that has no intrinsic DNA-
binding activity (25), thus its interaction with the
chromatin occurs via protein–protein interactions that
are preserved in the absence of crosslinking. By ﬂexibly
interacting with diﬀerent kinds of DNA-binding proteins,
many complexes can be assembled around a Sin3A core,
and by adding new components, the speciﬁc activities of
other factors may be drastically modiﬁed, providing a
combinatorial tool for both positive and negative tran-
scriptional regulation (25).
Application of N-ChIP forthe analysis of Runx2-binding
sites inthe murinebone sialoprotein (Bsp) promoter
In a previous study, we analyzed Runx2 binding elements
in the 2.5-kb promoter region of the Bsp gene (6). In that
paper, we used X-ChIP to examine the in vivo association
of Runx2 with proximal ( 209bp) and distal ( 1335bp)
promoter regions (Figure 3A) in osteoblast-like MC-4
cells. First, we discovered that a putative binding site
(R3 in Figure 3A) that perfectly matches the OSE2
Runx2-enhancer in the Ocn promoter is not associated
Figure 2. N-ChIP successfully detects interactions of multiple nuclear
factors with osteoblast chromatin. Chromatin fragments were immu-
noprecipitated using antibodies raised to the following proteins; Runx2,
Dlx6, mSin3A and acetylated-histone3. A negative controls using
nonspeciﬁc normal rabbit or goat IgGs were also included. The PCR
analysis was performed using the primer pair P1-P2 in the downstream
region of the Ocn promoter were the OSE2a site is located.
Figure 3. N-ChIP analysis of Runx2-binding sites in the Bsp promoter.
(A) Schematic representation of the Runx2-binding sites in the
proximal murine Bsp promoter. The putative Runx2-binding sites R1,
R2 and the previously described R3 site ( 1335) are indicated.
C denotes a homeodomain-protein-binding site that interacts with the
Runx2 bound to the R2 site. Primers P7-P8 amplify the downstream
region of the Bsp promoter that includes sites R1 and R2. (B) N-ChIP
competition assay for the Bsp promoter. The N-ChIP competition
assays were performed using ds-oligos containing the intact sites R1
and R2 (oligos: C-R1, C-R2) or their respective mutant oligos (M-R1a,
M-R1b, M-R2) as described in the text. Competing ds-oligos were used
at diﬀerent concentrations: 75, 225, 375, 525 and 750nM. Note that
two mutant oligos were made to the R1 site (a and b). The M-R1a
oligo contains a mutation in the Runx2 consensus while M-R1b has a
mutation in the adjacent 50 region (see Table 1). Control reactions
were included with no-competing oligo and using nonspeciﬁc normal
rabbit IgG. The gels are ethidium bromide-stained agarose gels of
the PCR products obtained with ChIP-DNAs using the primers P7-P8.
The experiment was repeated two times with similar results.
(C) Electrophoresis mobility shift assay showing that Runx2 binds to
the R2 site from the Bsp promoter with lower aﬃnity than to R1.
Runx2 binding to R1 and R2 containing ds oligonucleotides was
analyzed by EMSA combined with supershift using Runx2 antibody.
Labeled (probe) R1 or R2 was incubated with MC4 nuclear extracts
and the competition experiment was performed in each case with
unlabeled (cold) wild-type oligos (R1 and R2). No competition was
seen with oligos containing mutations in the Runx2-binding sites (data
not shown). In the assay, MC-4 nuclear extracts were pre-incubated
with Runx2 antibody prior to their incubation with the mixture of
probe and the cold-competing oligos. The experiment was performed
with the indicated molar excess of cold-competing oligos. The
sequences of oligos R1, R2, mR1 and mR2 as well as the details of
the EMSA appear described in our previous paper (6). The black arrow
indicates the supershifted Runx2-bound complexes. Also shown is the
gel shift pattern for R1 and R2 probes in the absence of anti-Runx2
antibody and competing oligonucleotides (right 2 lanes).
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Runx2 in vitro (26). In contrast, using ChIP assays we
observed a direct binding of Runx2 to the proximal
promoter region delineated by P7 and P8 primers
(Figure 3A). Two adjacent Runx2-binding sequences
(R1 and R2, Figure 3A) were identiﬁed in this region.
Mutation of both R1 and R2 sites was required to abolish
Runx2 association with this region of chromatin as
measured by X-ChIP. Thus, Runx2 is bound to both R1
and R2 sites in vivo (6).
Having studied this promoter in detail, we wanted to
know what new information could obtained using the
competitive N-ChIP method. First, we conﬁrmed our
previous X-ChIP result (6) by showing that Runx2 does
not interact with the R3 site after N-ChIP (data not
shown). Thus, even in the absence of crosslinking, Runx2
remains associated with its in vivo sites in the Bsp
promoter and does not alter its distribution to become
associated with a cryptic nonphysiological site. The
competitive N-ChIP method was then used to analyze
Runx2 binding to the proximal promoter region (in or
adjacent to the fragment ampliﬁed by primers P7-P8). The
ds-oligos used for competitive ChIP assays contained the
intact sites R1 and R2 (C-R1, C-R2) and the correspond-
ing mutants (M-R1a, M-R2) each containing a 2-bp
mutation in the Runx2 consensus sequence that abolished
Runx2 binding in vitro (6,26). Furthermore, in the case of
R1, we also included an oligo (designated M-R1b)
containing a 2-bp mutation in the adjacent region 50 to
the R1 site (see Table 1). The results of a representative
ChIP-competition experiment using increasing concentra-
tions of oligonucleotides (75, 225, 375, 525 and 750nM)
are shown in Figure 3B. The wild type R1 oligo (C-R1)
was able to displace Runx2 from chromatin; however
neither the R2 oligo (C-R2) nor any of the mutant oligos
including the R1b oligo had any detectable competition
activity. We interpret these results as follows: Because
R1 and R2 are only separated by 54bp, the P7-P8 primer
pair ampliﬁes DNA fragments containing both sites.
Therefore, the fact that C-R1 oligo is able to inhibit the
ChIP signal indicates that this oligo is displacing Runx2
from both R1 and R2 sites. In contrast, C-R2 was unable
to disrupt Runx2 binding. Therefore, the aﬃnity of Runx2
for the R2 site must be weaker than for R1. This
interpretation is supported by results from EMSA analysis
using ds oligos containing each site (Figure 3C). As
shown, C-R1 was able to eﬃciently compete binding of
Runx2 to labeled oligos containing either R1 or R2 sites
(shown with supershift assays in the presence of anti-
Runx2 antibody). In contrast, C-R2 could only compete
Runx2 binding to labeled R2 oligo; it was a much weaker
competitor of binding to R1. Densitometric analysis of the
supershifted species showed that a 10-fold molar excess of
C-R1 reduced binding to labeled R1 and R2 oligos by 58
and 89%, respectively, while the same molar excess of
C-R2 reduced binding to R1 oligo by only 32% and to R2
oligo by 65%. Consistent with these results, our previous
functional analysis of R1 and R2 sites indicated that R2 is
active only in cooperation with an adjacent homeodo-
main-protein-binding site known to bind the Dlx5
transcription factor (C-site in Figure 3A), which may
stabilize the Runx2 bound to R2 (6).
DISCUSSION
Here we describe a new method for the immunoprecipita-
tion of chromatin isolated from cells in the absence of
crosslinking (N-ChIP) as well as the use of oligonucleotide
competition as a means of assessing the speciﬁcity and
relative aﬃnity of transcription factors for speciﬁc
enhancer sites in target genes. We speciﬁcally used this
assay to evaluate interactions between Runx2 and its
cognate binding sites in regulatory regions of Ocn and
Bsp, two genes that are tightly regulated by Runx2 in
osteoblasts. Quantiﬁcation of results for Ocn using real-
time PCR allowed us to compare diﬀerences in Runx2-
binding aﬃnity between OSE2a and OSE2b enhancers in
chromatin. For Bsp, we observed even more striking
diﬀerences in relative aﬃnity of Runx2 for R1 and R2 sites
(Figure 3B). Results obtained with competitive ChIP
assays are consistent with our previous functional studies
as well as EMSA competition experiments. Taken
together, our results indicate that competitive N-ChIP
can be used to detect protein–nucleic acid and protein–
protein interactions on native chromatin, a ﬁnding that
may have many applications in the study of gene
regulation.
In the absence of crosslinking, the interaction of a
nuclear factor with chromatin, like all noncovalent
interactions, is deﬁned by an equilibrium between bound
and free factor. This lack of covalent attachment
introduces the possibility that nuclear factors might
dissociate from chromatin or become associated with
nonphysiological sites during chromatin isolation and
shearing. However, in many cases, chromatin complexes
can be suﬃcient stable to be detected without crosslinking.
The best example of this is the nucleosome, which is held
together by high-aﬃnity histone–DNA and histone–
histone interactions (27). As shown in the present work,
certain bone-related transcription factors (Runx2, Dlx6
and mSin3a) also form stable complexes with their
cognate DNA-binding sites in chromatin. For example,
minimal dissociation of Runx2 from chromatin was seen
in N-ChIP samples even after overnight incubation at 48C
in the absence of competing oligonucleotides (Figure 1B,
lanes 1 and 2). In fact, comparable PCR signals were
obtained when X-ChIP and N-ChIP samples were
compared (Figure 1A versus 1B). Only when OSE2-
containing oligos were added did we see dissociation of
Runx2 from chromatin. In this case, oligos were added in
vast ( 50000-fold) excess relative to the number of
Runx2-binding sites present in chromatin. Under these
conditions, the added oligo can trap Runx2 as it
dissociates from chromatin. In contrast, when no oligo
or oligo with a mutated OSE2 site was added, no Runx2
trapping occurred and the Runx2-chromatin complex was
preserved (Figures 1B and 2). We also think it unlikely
that Runx2 can dissociate from chromatin and nonspeci-
ﬁcally re-associate with nonphysiological sites during
N-ChIP. The Bsp promoter gave us a good opportunity
1728 Nucleic Acids Research, 2008, Vol. 36, No. 5to address this issue. This promoter contains three sites,
designated R1, R2 and R3 (at  83,  184 and  1335bp,
respectively) that all bind Runx2 when examined by
EMSA in vitro. However, as was previously shown by
X-ChIP, only R1 and R2 bind Runx2 in vivo. Similarly,
occupancy of R1 and R2 was clearly detected by N-ChIP
while no Runx2 binding was detected in the  1335-bp
region (Figure 3B), arguing against any Runx2 redistribu-
tion taking place even in the absence of crosslinking.
Although we have not applied N-ChIP analysis to
nonbone derived cells, it is likely that this approach will be
widely applicable to the study of protein–chromatin
interactions in many other cell types. Because aﬃnities
for chromatin are likely to be highly variable, results of
N-ChIP must obviously be conﬁrmed with X-ChIP
whenever a new factor is being examined.
The competitive N-ChIP approach we describe may
have a number of applications related to the study of
transcriptional regulation. These include the following:
(i) Measuring the aﬃnity of nuclear factors for
chromatin. As shown in the present work, competitive
ChIP can be used to compare the relative aﬃnity of
transcription factors for previously known enhancers in
the context of native chromatin. This may be particularly
informative in cases where a given nuclear factor interacts
at multiple sites within the same gene that may be
selectively active as levels of factor ﬂuctuate. We show
examples of this in both Ocn and Bsp promoters (Figures 1
and 3). In both cases, diﬀerences in Runx2 association
with two distinct enhancers could be related to diﬀerences
in transcriptional activity. Thus, in Ocn we detected a
relatively higher aﬃnity interaction between Runx2 and
OSE2a when compared with OSE2b. Since OSE2a and
OSE2b are separated by  500bp, their individual inter-
actions with Runx2 could be clearly resolved by ChIP
using separate PCR primers. Previous studies also showed
preferential binding of Runx2 to OSE2a versus OSE2b
using EMSA analysis and provided evidence for prefer-
ential regulation of Ocn expression via OSE2a in cell
culture and in vivo (19). A similar situation was found for
the Bsp promoter. In this case, however, the two Runx2
sites are separated by only 54bp, making it impossible to
directly resolve their separate interactions by ChIP/PCR.
However, diﬀerences in binding aﬃnity could be inferred
from the observation that only R1 oligo was able to
inhibit the ChIP signal. Since this could only happen if
Runx2 binding was competed at both sites, R1 must be
able to block both interactions. In contrast, R2 was
unable to disrupt Runx2 binding. As was the case for Ocn,
these observations are consistent with EMSA analysis and
previous functional studies (6). This type of analysis may
prove quite useful for resolving protein–chromatin inter-
actions on other genes as well.
(ii) Identiﬁcation of new binding sites/enhancers.
Competitive N-ChIP will be particularly helpful in the
analysis transcription factors for which the DNA-binding
motif is currently unknown or has not been previously
characterized. In this case, the gene under investigation or
the entire genome could ﬁrst be screened to ﬁnd
transcription factor binding regions that could then be
further resolved using competitive N-ChIP assays with
oligonucleotides corresponding to consensus binding sites
within speciﬁc regions of interest. Finally, mutational
analysis could be used to functionally characterize these
sites. This approach could be used with traditional ChIP/
PCR analysis as well as ChIP on Chip or high-throughput
sequencing strategies (27). Although the size of oligos used
in the present study was  30bp, this size could be
increased or decreased to simplify the screening procedure.
(iii) Identiﬁcation of binding sites for nuclear proteins
that do not directly interact with DNA. We demonstrated
that N-ChIP can detect binding of Sin3A to chromatin
(Figure 2). Because this protein lacks a DNA-binding
motif, it can only interact with chromatin by ﬁrst
binding to nuclear factors that have inherent DNA-
binding activity. The ability to detect this type of protein–
protein interaction using N-ChIP obviously depends on
the strength of the interaction being studied with only
high-aﬃnity interactions being able to survive chromatin
isolation and shearing procedures. For those interactions
that do survive, competitive N-ChIP could be used to
identify DNA sequences required for association of the
factor of interest with chromatin, and this information
could then be used to infer which DNA-binding factors
account for the observed chromatin association.
(iv) Isolation of transcription factor complexes. Our
observation that Runx2 can be displaced from chromatin
by double-stranded oligonucleotides containing a Runx2-
binding site suggests a possible strategy for puriﬁcation of
transcription factor complexes. This approach would
involve initial isolation of chromatin fragments containing
a particular transcription factor using either antibodies or
expression of an aﬃnity-tagged factor followed by
displacement of the transcription factor and associated
proteins using a speciﬁc oligonucleotide.
In summary, we developed a simple and eﬃcient
N-ChIP procedure that, when combined with oligonucleo-
tide competition, will be an important tool for studying
chromatin structure and function.
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